Pharmafile Logo
Pharmafocus logo
Advanced Search

pharma

Showing 15 posts of 2914 posts found.

top_10_image

Top Ten most popular articles on Pharmafile.com this week

October 12, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing WHO, biosimilars. GSK, manufacturing, pharma, top 10

Politics played a big role in pharma this week after Trump introduced legislation aimed at reducing the price of drugs. …

News
trvn1

Trevena’s opioid injection fails to win over FDA committee

October 12, 2018
Medical Communications, Sales and Marketing FDA, Trevena, US, oliceridine, opioid, opioid crisis, pharma

Trevena has seen its opioid injection oliceridine fail to win over an FDA advisory panel in the management of acute …

News
roche__tree

Roche’s Ocrevus shows earlier, better outcomes in primary progressive and relapsing MS

October 11, 2018
Research and Development Ocrevus, Roche, multiple sclerosis, pharma

Roche has unveiled new five-year data from three Phase 3 open-label extension studies investigating the efficacy of Ocrevus (ocrelizumab) in …

News

NICE recommends first new X-linked hypophosphataemia therapy in over 30 years

October 10, 2018
Research and Development, Sales and Marketing Crysvita, Kyowa Kirin International, NHS, NICE, X-linked hypophosphataemia, pharma

NICE has announced its evidence-based recommendation that Kyowa Kirin International’s Crysvita (burosumab) be made available on the NHS for the …

News
novartis_outside_1

Novartis’ sickle cell drug reduces vaso-occlusive crises by 35% at Phase 2

October 10, 2018
Research and Development Novartis, crizanlizumab, pharma, sickle cell disease

Novartis has presented new Phase 2 data for its humanised anti-P-selectin monoclonal antibody crizanlizumab in the treatment of sickle cell …

News
janssen_latest_logo_on_sign_closer

Janssen’s Stelara shows promise across two dosages in ulcerative colitis

October 9, 2018
Manufacturing and Production, Research and Development Janssen, Stelara, pharma, ulcerative colitis

Janssen’s biologic therapy Stelara (ustekinumab) has shown new efficacy in the treatment of moderate to severe ulcerative colitis in two …

News
celgene_1_02

Celgene’s Otezla impresses at Phase 3 in scalp psoriasis

October 9, 2018
Manufacturing and Production, Research and Development Celgene, pharma, psoriasis

Celgene has unveiled new Phase 3 data for Otezla (apremilast), its inhibitor of phosphodiesterase 4 (PDE4) specific for cyclic adenosine …

News
shutterstock_138095450_13

New hospital-led organisation aims to tackle drug pricing problem by manufacturing generic drugs

October 9, 2018
Manufacturing and Production PhRMA, aha, generics, hospitals, non profit, non-profit, pharma

Seven organisations representing around 500 US hospitals have become the governing members of a newly established initiative aimed at reducing …

News
capture

The economics of mental health

October 8, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing HEOR, health economics and outcomes research, mental health, pharma

Louis Goss examines mental health from a health economics and outcomes research (HEOR) perspective and asks what might be done …

Feature

NICE recommends Pfizer’s Mylotarg combo in CD33-positive acute myeloid leukaemia

October 8, 2018
Sales and Marketing Mylotarg, NICE, Pfizer, acute myeloid leukaemia, leukaemia, pharma

NICE has revealed its recommendation for Pfizer’s Mylotarg (gemtuzumab ozogamicin) to be used on the NHS in the treatment of …

News
alzheimers_sq

Tech firm Tencent aims for 3-minute Alzheimer’s diagnosis with new partnership

October 8, 2018
Research and Development, Sales and Marketing Alzheimer's, pharma, tencent

Chinese tech firm Tencent has partnered up with London-based healthcare technology firm Medopad in a big to accelerate the diagnosis …

News
gsk_boronia_australia

GSK to cut almost 200 jobs at UK site

October 5, 2018
Manufacturing and Production, Medical Communications GSK, UK, Ulverston, job cuts, pharma

GlaxoSmithKline has announced that it is to slash half of its workforce at its site in Ulverston, UK, as part …

News
roche_dark_0

FDA expands indication of Roche’s Hemlibra in haemophilia

October 5, 2018
Medical Communications, Sales and Marketing Hemlibra, Roche, haemophilia, pharma

The FDA has chosen to expand the label of Roche’s Hemlibra (emicizumab-kxwh), approving it for routine prophylaxis to prevent the …

News
ianread

Ian Read steps down as Pfizer CEO

October 4, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing CEO, Ian Read, Pfizer, pharma

Ian Read is set to step down from his position as Chief Executive Officer (CEO) of American pharma firm Pfizer, …

Appointment
boardroom

The value of measuring biotech Board performance

October 4, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing RSA Group, biotech, board, life sciences, opinion, pharma

Nick Stephens of The RSA Group discusses the importance of stopping to quantify the effectiveness of board members within life …

Feature
The Gateway to Local Adoption Series

Latest content

BMS’ Opdivo/Yervoy combination accepted by Scottish Medicines Consortium for colorectal cancer

February 5, 2026

AstronauTx appoints Adam Rosenberg as Chair of the Board

February 5, 2026

Astellas Pharma’s Vyloy accepted by Scottish Medicines Consortium for gastric cancer

February 4, 2026

Angelini Pharma appoints Sergio Marullo di Condojanni as CEO

February 4, 2026

QV Bioelectronics secures £4.5m in funding for brain cancer therapy development

February 3, 2026